14 mars, 2022
Kallelse till extra bolagsstämma i respiratorius AB (publ)
Aktieägarna i Respiratorius AB (publ), 556552-2652, (”Respiratorius”), kallas härmed till extra bolagsstämma måndagen den 14 mars 2022 kl. 13.00 på Medicon Village i huvudbyggnaden The Spark, konferensrum Collaboraction, Scheeletorget 1, Lund.
In Short
Respiratorius AB (publ) develops drug candidates with the goal of launching drugs to treat common diseases such as cancer, chronic obstructive pulmonary disease (COPD) and severe asthma. The project portfolio also includes a project for improving the diagnosis of certain cardiovascular diseases using PET imaging.
CONTACT
Respiratorius AB
Medicon Village
Scheelevägen 2, 223 81 Lund, Sweden
info@respiratorius.com
+46 70 922 41 40
